Nanopharmaceuticals (part 1): products on the market
Volkmar Weissig,1 Tracy K Pettinger,2 Nicole Murdock3 1Department of Pharmaceutical Sciences, Midwestern University College of Pharmacy Glendale, Glendale, AZ, USA; 2Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, Idaho State University, Pocatello, ID, USA; 3Depar...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/1926aedc638440418448533da8e55d08 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:1926aedc638440418448533da8e55d08 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:1926aedc638440418448533da8e55d082021-12-02T05:00:28ZNanopharmaceuticals (part 1): products on the market1178-2013https://doaj.org/article/1926aedc638440418448533da8e55d082014-09-01T00:00:00Zhttp://www.dovepress.com/nanopharmaceuticals-part-1-products-on-the-market-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013 Volkmar Weissig,1 Tracy K Pettinger,2 Nicole Murdock3 1Department of Pharmaceutical Sciences, Midwestern University College of Pharmacy Glendale, Glendale, AZ, USA; 2Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, Idaho State University, Pocatello, ID, USA; 3Department of Pharmacy Practice, Midwestern University College of Pharmacy Glendale, Glendale, AZ, USA Abstract: In 2000, the National Institute of Health launched the National Nanotechnology Initiative to support, coordinate, and advance research and development of nanoscale projects. The impact of this new program on health-science related research and development became quickly visible. Broad governmental financial support advanced the start of new, and the deepening of already existing, interdisciplinary research. The anticipated merger of nanoscience with medicine quickly instigated the conceptualization of nanomedicine. The adoption of nanoscience terminology by pharmaceutical scientists resulted in the advent of nanopharmaceuticals. The term “nano” became tantamount to “cutting-edge” and was quickly embraced by the pharmaceutical science community. Colloidal drug delivery systems reemerged as nanodrug delivery systems; colloidal gold became a suspension of nano gold particles. In this review, we first review nanoscience related definitions applied to pharmaceuticals, we then discuss all 43 currently approved drug formulations which are publicized as nanopharmaceuticals, and finally we analyze clinical aspects of selected drug formulations. Keywords: amphotericin-B, fenofibrate, nanodrugs, nanomedicine, nanoparticle, drug deliveryWeissig VPettinger TKMurdock NDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 4357-4373 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Weissig V Pettinger TK Murdock N Nanopharmaceuticals (part 1): products on the market |
| description |
Volkmar Weissig,1 Tracy K Pettinger,2 Nicole Murdock3 1Department of Pharmaceutical Sciences, Midwestern University College of Pharmacy Glendale, Glendale, AZ, USA; 2Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, Idaho State University, Pocatello, ID, USA; 3Department of Pharmacy Practice, Midwestern University College of Pharmacy Glendale, Glendale, AZ, USA Abstract: In 2000, the National Institute of Health launched the National Nanotechnology Initiative to support, coordinate, and advance research and development of nanoscale projects. The impact of this new program on health-science related research and development became quickly visible. Broad governmental financial support advanced the start of new, and the deepening of already existing, interdisciplinary research. The anticipated merger of nanoscience with medicine quickly instigated the conceptualization of nanomedicine. The adoption of nanoscience terminology by pharmaceutical scientists resulted in the advent of nanopharmaceuticals. The term “nano” became tantamount to “cutting-edge” and was quickly embraced by the pharmaceutical science community. Colloidal drug delivery systems reemerged as nanodrug delivery systems; colloidal gold became a suspension of nano gold particles. In this review, we first review nanoscience related definitions applied to pharmaceuticals, we then discuss all 43 currently approved drug formulations which are publicized as nanopharmaceuticals, and finally we analyze clinical aspects of selected drug formulations. Keywords: amphotericin-B, fenofibrate, nanodrugs, nanomedicine, nanoparticle, drug delivery |
| format |
article |
| author |
Weissig V Pettinger TK Murdock N |
| author_facet |
Weissig V Pettinger TK Murdock N |
| author_sort |
Weissig V |
| title |
Nanopharmaceuticals (part 1): products on the market |
| title_short |
Nanopharmaceuticals (part 1): products on the market |
| title_full |
Nanopharmaceuticals (part 1): products on the market |
| title_fullStr |
Nanopharmaceuticals (part 1): products on the market |
| title_full_unstemmed |
Nanopharmaceuticals (part 1): products on the market |
| title_sort |
nanopharmaceuticals (part 1): products on the market |
| publisher |
Dove Medical Press |
| publishDate |
2014 |
| url |
https://doaj.org/article/1926aedc638440418448533da8e55d08 |
| work_keys_str_mv |
AT weissigv nanopharmaceuticalspart1productsonthemarket AT pettingertk nanopharmaceuticalspart1productsonthemarket AT murdockn nanopharmaceuticalspart1productsonthemarket |
| _version_ |
1718400815620685824 |